June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Enhanced Riboflavin Stromal Delivery Using Microchannel-assisted Iontophoresis for Corneal Crosslinking (CXL)
Author Affiliations & Notes
  • Rohan Joshi
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
    School of Engineering, University of California Irvine, Irvine, California, United States
  • Samantha Bradford
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Emily Farrah
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Shangbang Luo
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
    School of Engineering, University of California Irvine, Irvine, California, United States
  • Yilu Xie
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Donald J Brown
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Tibor Juhasz
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
    School of Engineering, University of California Irvine, Irvine, California, United States
  • James V Jester
    Opthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
    School of Engineering, University of California Irvine, Irvine, California, United States
  • Footnotes
    Commercial Relationships   Rohan Joshi None; Samantha Bradford None; Emily Farrah None; Shangbang Luo None; Yilu Xie None; Donald Brown None; Tibor Juhasz None; James Jester None
  • Footnotes
    Support  NIH EY024600, RPB 203478, Discovery Eye Foundation
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3587. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rohan Joshi, Samantha Bradford, Emily Farrah, Shangbang Luo, Yilu Xie, Donald J Brown, Tibor Juhasz, James V Jester; Enhanced Riboflavin Stromal Delivery Using Microchannel-assisted Iontophoresis for Corneal Crosslinking (CXL). Invest. Ophthalmol. Vis. Sci. 2023;64(8):3587.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Transepithelial Ultraviolet Corneal Crosslinking (TE UVA CXL) has been shown to mitigate some of the negative side effects of standard UVA CXL by avoiding epithelial debridement, although crosslinking is less effective due to the reduced Riboflavin (Rf) penetration into the stroma. While femtosecond (FS) based micro-machining to form epithelial microchannels (MC) can greatly improve Rf stromal penetration, this procedure still requires 30 minutes of Rf application to achieve maximum stromal delivery equivalent to 50% of that obtained with complete epithelial removal. The purpose of this study was to determine if iontophoresis of Rf combined with MC could both shorten the treatment time for MC and also improve Rf stromal delivery by iontophoresis.

Methods : Eighty-four ex vivo rabbit eyes were divided into three groups: G1, iontophoresis alone; G2, iontophoresis with MC; and G3, MC alone. Iontophoresis was performed using a small electric current (Iontofor-CXL, OPIA Technologies) to transport Rf into the stroma, varying both current and time. MCs were generated using a 1030 nm FS laser (Chameleon, Coherent Inc.) with 5μJ pulse energy to machine the corneal epithelial surface in a 6mm diameter region. All eyes were treated with topical iso-osmolar (300 mOsmol/l) Rf solution (1.0% riboflavin-5-phosphate in PBS), and stromal Rf concentration was determined spectrophotometrically by eluting Rf from 6 mm diameter stromal buttons placed in 1 ml of PBS overnight.

Results : Iontophoresis alone (G1, n = 31) achieved Rf stromal concentrations of 4.73 ± 0.82 ug/ml (1 mA for 10 min), 4.18 ± 0.42 ug/ml (1 mA for 5 min), and 3.65 ± 0.23 ug/ml (0.5 mA for 10 min) which were not significantly different. Using the same Iontophoresis exposures combined with MC (G2, n = 48) achieved significantly higher (P < 0.001*) Rf concentrations of 12.64 ± 1.82 ug/ml, 10.37 ± 2.28 ug/ml, and 12.8 ± 1.38 ug/ml respectively. Furthermore, Iontophoresis for 10 minutes at 0.5 or 1 mA achieved the same stromal concentration as MC alone with 30 minutes treatment.

Conclusions : A combined treatment of MCs and low current iontophoresis produces a significantly higher stromal Rf concentration than iontophoresis alone and equivalent to MC alone at a greatly reduced Rf treatment time.

Supported by: NIH EY024600, RPB 203478, Discovery Eye Foundation

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×